Home » Topics » BioWorld Science

BioWorld Science
RSS

Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469

May 10, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics

May 10, 2018

IGEM Therapeutics awarded grant from Innovate UK

May 10, 2018

AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.

May 10, 2018

Novel Ironwood soluble guanylate cyclase stimulator reduces neuroinflammation

May 10, 2018

Development of Wayshine Biopharm compounds advances for brain and lung cancer

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...